{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:43:40Z","timestamp":1791845020867,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07309-1","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:13:00Z","timestamp":1764915180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CXCL12 deficiency promotes colorectal cancer progression and reduces anti-PD-L1 immunotherapy efficacy through MDSC regulation"],"prefix":"10.1186","volume":"23","author":[{"given":"Heping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manzhen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sainan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junni","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"7309_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2020.12.025","volume":"31","author":"X Huang","year":"2021","unstructured":"Huang X, Zhu X, Yu Y, Zhu W, Jin L, Zhang X, et al. Dissecting miRNA signature in colorectal cancer progression and metastasis. Cancer Lett. 2021;31:66\u201382. https:\/\/doi.org\/10.1016\/j.canlet.2020.12.025.","journal-title":"Cancer Lett"},{"key":"7309_CR2","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, et al. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065. https:\/\/doi.org\/10.1038\/nrdp.2015.65.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"7309_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336. https:\/\/doi.org\/10.1016\/j.tips.2023.01.003.","journal-title":"Trends Pharmacol Sci"},{"key":"7309_CR4","first-page":"2480","volume":"10","author":"K Li","year":"2020","unstructured":"Li K, Huang F, Li Y, Li D, Lin H, Ni R, et al. Stabilization of oncogenic transcripts by the IGF2BP3\/ELAVL1 complex promotes tumorigenicity in colorectal cancer. Am J Cancer Res. 2020;10:2480\u201394.","journal-title":"Am J Cancer Res"},{"key":"7309_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-1221-6_1","volume":"825","author":"S Gerstberger","year":"2014","unstructured":"Gerstberger S, Hafner M, Ascano M, Tuschl T. Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease. Adv Exp Med Biol. 2014;825:1\u201355. https:\/\/doi.org\/10.1007\/978-1-4939-1221-6_1.","journal-title":"Adv Exp Med Biol"},{"key":"7309_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.trecan.2017.05.003","volume":"3","author":"B Pereira","year":"2017","unstructured":"Pereira B, Billaud M, Almeida R. RNA-binding proteins in cancer: old players and new actors. Trends Cancer. 2017;3:506\u201328. https:\/\/doi.org\/10.1016\/j.trecan.2017.05.003.","journal-title":"Trends Cancer"},{"key":"7309_CR7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.21873\/anticanres.11511","volume":"37","author":"HH Jang","year":"2017","unstructured":"Jang HH, Lee HN, Kim SY, Hong S, Lee WS. Expression of RNA-binding motif protein 3 (RBM3) and cold-inducible RNA-binding protein (CIRP) is associated with improved clinical outcome in patients with colon cancer. Anticancer Res. 2017;37:1779\u201385. https:\/\/doi.org\/10.21873\/anticanres.11511.","journal-title":"Anticancer Res"},{"key":"7309_CR8","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.bbrc.2019.04.103","volume":"513","author":"Y Long","year":"2019","unstructured":"Long Y, Marian TA, Wei Z. ZFR promotes cell proliferation and tumor development in colorectal and liver cancers. Biochem Biophys Res Commun. 2019;513:1027\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2019.04.103.","journal-title":"Biochem Biophys Res Commun"},{"key":"7309_CR9","doi-asserted-by":"publisher","first-page":"21404","DOI":"10.18632\/aging.103893","volume":"12","author":"Y Fang","year":"2020","unstructured":"Fang Y, Zhong Q, Wang Y, Gu C, Liu S, Li A, et al. CPEB3 functions as a tumor suppressor in colorectal cancer via JAK\/STAT signaling. Aging (albany, NY). 2020;12:21404\u201322. https:\/\/doi.org\/10.18632\/aging.103893.","journal-title":"Aging (albany, NY)"},{"key":"7309_CR10","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1186\/s12885-018-4931-3","volume":"18","author":"Z Zeng","year":"2018","unstructured":"Zeng Z, Yang H, Xiao S. ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer. BMC Cancer. 2018;18:1020. https:\/\/doi.org\/10.1186\/s12885-018-4931-3.","journal-title":"BMC Cancer"},{"key":"7309_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/cgt.2012.70","volume":"19","author":"H Lin","year":"2012","unstructured":"Lin H, Zhang Y, Wang H, Xu D, Meng X, Shao Y, et al. Tissue inhibitor of metalloproteinases-3 transfer suppresses malignant behaviors of colorectal cancer cells. Cancer Gene Ther. 2012;19:845\u201351. https:\/\/doi.org\/10.1038\/cgt.2012.70.","journal-title":"Cancer Gene Ther"},{"key":"7309_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1309\/AJCPK35VZJEWCUTL","volume":"132","author":"Y Akishima-Fukasawa","year":"2009","unstructured":"Akishima-Fukasawa Y, Nakanishi Y, Ino Y, Moriya Y, Kanai Y, Hirohashi S. Prognostic significance of CXCL12 expression in patients with colorectal carcinoma. Am J Clin Pathol. 2009;132:202\u201310; quiz 307. doi: https:\/\/doi.org\/10.1309\/AJCPK35VZJEWCUTL.","journal-title":"Am J Clin Pathol"},{"key":"7309_CR13","doi-asserted-by":"publisher","unstructured":"Go\u00efta AA, Guenot D. Colorectal cancer: the contribution of CXCL12 and its receptors CXCR4 and CXCR7. cancers (Basel). 2022;14(7):1810. https:\/\/doi.org\/10.3390\/cancers14071810.","DOI":"10.3390\/cancers14071810"},{"issue":"46","key":"7309_CR14","doi-asserted-by":"publisher","first-page":"28960","DOI":"10.1073\/pnas.2013644117","volume":"117","author":"D Biasci","year":"2020","unstructured":"Biasci D, Smoragiewicz M, Connell CM, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117(46):28960\u201370. https:\/\/doi.org\/10.1073\/pnas.2013644117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"7309_CR15","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.3390\/ijms22147371","volume":"22","author":"T Khare","year":"2021","unstructured":"Khare T, Bissonnette M, Khare S. CXCL12-CXCR4\/CXCR7 axis in colorectal cancer: therapeutic target in preclinical and clinical studies. Int J Mol Sci. 2021;22(14):7371. https:\/\/doi.org\/10.3390\/ijms22147371.","journal-title":"Int J Mol Sci"},{"key":"7309_CR16","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.3748\/wjg.v23.i28.5167","volume":"23","author":"JC Ma","year":"2017","unstructured":"Ma JC, Sun XW, Su H, Chen Q, Guo TK, Li Y, et al. Fibroblast-derived CXCL12\/SDF-1\u03b1 promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K\/Akt\/mTOR pathway in colon cancer. World J Gastroenterol. 2017;23:5167\u201378. https:\/\/doi.org\/10.3748\/wjg.v23.i28.5167.","journal-title":"World J Gastroenterol"},{"key":"7309_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.semcancer.2019.12.007","volume":"65","author":"SK Daniel","year":"2020","unstructured":"Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4\/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Semin Cancer Biol. 2020;65:176\u201388. https:\/\/doi.org\/10.1016\/j.semcancer.2019.12.007.","journal-title":"Semin Cancer Biol"},{"key":"7309_CR18","doi-asserted-by":"publisher","unstructured":"Yu W, et al. The connection between surgical margins in liver metastases from colorectal cancer and patient prognosis: a mini review. Curr Probl Surg. 63(2025):101700. https:\/\/doi.org\/10.1016\/j.cpsurg.2024.101700.","DOI":"10.1016\/j.cpsurg.2024.101700"},{"key":"7309_CR19","doi-asserted-by":"publisher","first-page":"622659","DOI":"10.3389\/fgene.2020.622659","volume":"11","author":"F Yang","year":"2021","unstructured":"Yang F, Cai S, Ling L, Zhang H, Tao L, Wang Q. Identification of a five-gene prognostic model and its potential drug repurposing in colorectal cancer based on TCGA, GTEx and GEO databases. Front Genet. 2021;11:622659. https:\/\/doi.org\/10.3389\/fgene.2020.622659.","journal-title":"Front Genet"},{"key":"7309_CR20","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.18632\/aging.202589","volume":"13","author":"T Yue","year":"2021","unstructured":"Yue T, Chen S, Zhu J, Guo S, Huang Z, Wang P, et al. The aging-related risk signature in colorectal cancer. Aging (albany, NY). 2021;13:7330\u201349. https:\/\/doi.org\/10.18632\/aging.202589.","journal-title":"Aging (albany, NY)"},{"key":"7309_CR21","doi-asserted-by":"publisher","first-page":"1003419","DOI":"10.3389\/fimmu.2022.1003419","volume":"13","author":"S Xie","year":"2023","unstructured":"Xie S, Cai Y, Chen D, Xiang Y, Cai W, Mao J, Ye J. Single-cell transcriptome analysis reveals heterogeneity and convergence of the tumor microenvironment in colorectal cancer. Front Immunol. 2023;13:1003419. https:\/\/doi.org\/10.3389\/fimmu.2022.1003419.","journal-title":"Front Immunol"},{"key":"7309_CR22","doi-asserted-by":"publisher","unstructured":"Harris BHL, Di Giovannantonio M, Zhang P, Harris DA. Lord SR, Allen NE, et al. New role of fat-free mass in cancer risk linked with genetic predisposition. Sci Rep. 2024;14:7270. https:\/\/doi.org\/10.1038\/s41598-024-54291-7.","DOI":"10.1038\/s41598-024-54291-7"},{"key":"7309_CR23","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53:1300\u201310. https:\/\/doi.org\/10.1038\/s41588-021-00913-z.","journal-title":"Nat Genet"},{"key":"7309_CR24","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.18632\/aging.204674","volume":"15","author":"F Peng","year":"2023","unstructured":"Peng F, Muhuitijiang B, Zhou J, Liang H, Zhang Y, Zhou R. An artificial neural network model to diagnose non-obstructive azoospermia based on RNA-binding protein-related genes. Aging (albany, NY). 2023;15:3120\u201340. https:\/\/doi.org\/10.18632\/aging.204674.","journal-title":"Aging (albany, NY)"},{"key":"7309_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"7309_CR26","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387.e29. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048.","journal-title":"Cell"},{"key":"7309_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13046-020-01637-4","volume":"39","author":"Q Zhong","year":"2020","unstructured":"Zhong Q, Fang Y, Lai Q, Wang S, He C, Li A, et al. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R\/STAT3 signaling. J Exp Clin Cancer Res. 2020;39:132. https:\/\/doi.org\/10.1186\/s13046-020-01637-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"7309_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12935-021-02031-6","volume":"21","author":"Q He","year":"2021","unstructured":"He Q, Li Z, Lei X, Zou Q, Yu H, Ding Y, et al. The underlying molecular mechanisms and prognostic factors of RNA binding protein in colorectal cancer: a study based on multiple online databases. Cancer Cell Int. 2021;21:325. https:\/\/doi.org\/10.1186\/s12935-021-02031-6.","journal-title":"Cancer Cell Int"},{"key":"7309_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12864-024-10295-1","volume":"25","author":"SL Schmit","year":"2024","unstructured":"Schmit SL, Tsai YY, Bonner JD, Sanz-Pamplona R, Joshi AD, Ugai T, et al. Germline genetic regulation of the colorectal tumor immune microenvironment. BMC Genomics. 2024;25:409. https:\/\/doi.org\/10.1186\/s12864-024-10295-1.","journal-title":"BMC Genomics"},{"key":"7309_CR30","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.7150\/jca.93789","volume":"15","author":"M Wang","year":"2024","unstructured":"Wang M, Zhang H, Lu Z, Su W, Tan Y, Wang J, et al. PSAT1 mediated EMT of colorectal cancer cells by regulating Pl3K\/AKT signaling pathway. J Cancer. 2024;15:3183\u201398. https:\/\/doi.org\/10.7150\/jca.93789.","journal-title":"J Cancer"},{"key":"7309_CR31","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/0284186X.2018.1433322","volume":"57","author":"TD Christensen","year":"2018","unstructured":"Christensen TD, Palshof JA, Larsen FO, Poulsen TS, H\u00f8gdall E, Pfeiffer P, et al. Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer. Acta Oncol. 2018;57:1057\u201362. https:\/\/doi.org\/10.1080\/0284186X.2018.1433322.","journal-title":"Acta Oncol"},{"key":"7309_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41419-020-02793-3","volume":"11","author":"HL Jiao","year":"2020","unstructured":"Jiao HL, Weng BS, Yan SS, Lin ZM, Wang SY, Chen XP, et al. Upregulation of OSBPL3 by HIF1A promotes colorectal cancer progression through activation of RAS signaling pathway. Cell Death Dis. 2020;11:571. https:\/\/doi.org\/10.1038\/s41419-020-02793-3.","journal-title":"Cell Death Dis"},{"key":"7309_CR33","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1021\/acschembio.5b00860","volume":"11","author":"MS Bousquet","year":"2016","unstructured":"Bousquet MS, Ma JJ, Ratnayake R, Havre PA, Yao J, Dang NH, et al. Multidimensional screening platform for simultaneously targeting oncogenic KRAS and hypoxia-inducible factors pathways in colorectal cancer. ACS Chem Biol. 2016;11:1322\u201331. https:\/\/doi.org\/10.1021\/acschembio.5b00860.","journal-title":"ACS Chem Biol"},{"issue":"1","key":"7309_CR34","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1038\/s41467-019-11530-0","volume":"10","author":"IG Serebriiskii","year":"2019","unstructured":"Serebriiskii IG, Connelly C, Frampton G, Newberg J, Cooke M, Miller V, et al. Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. Nat Commun. 2019, Aug, 19;10(1):3722. https:\/\/doi.org\/10.1038\/s41467-019-11530-0.","journal-title":"Nat Commun"},{"key":"7309_CR35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/PAI.0000000000000828","volume":"28","author":"A Ottaiano","year":"2020","unstructured":"Ottaiano A, Scala S, Normanno N, Botti G, Tatangelo F, Di Mauro A, et al. Prognostic and predictive role of CXC chemokine receptor 4 in metastatic colorectal cancer patients. Appl Immunohistochem Mol Morphol. 2020;28:755\u201360. https:\/\/doi.org\/10.1097\/PAI.0000000000000828.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"7309_CR36","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.21873\/anticanres.11830","volume":"37","author":"F Zheng","year":"2017","unstructured":"Zheng F, Zhang Z, Flamini V, Jiang WG, Cui Y. The axis of CXCR4\/SDF-1 plays a role in colon cancer cell adhesion through regulation of the AKT and IGF1R signalling pathways. Anticancer Res. 2017;37:4361\u201369. https:\/\/doi.org\/10.21873\/anticanres.11830.","journal-title":"Anticancer Res"},{"key":"7309_CR37","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.2174\/0929867326666190712151417","volume":"27","author":"E De Mattia","year":"2020","unstructured":"De Mattia E, Bignucolo A, Toffoli G, Cecchin E. Genetic markers of the host to predict the efficacy of colorectal cancer targeted therapy. Curr Med Chem. 2020;27:4249\u201373. https:\/\/doi.org\/10.2174\/0929867326666190712151417.","journal-title":"Curr Med Chem"},{"key":"7309_CR38","doi-asserted-by":"publisher","first-page":"ra92","DOI":"10.1126\/scisignal.2005411","volume":"7","author":"TJ Phesse","year":"2014","unstructured":"Phesse TJ, Buchert M, Stuart E, Flanagan DJ, Faux M, Afshar-Sterle S, et al. Partial inhibition of gp130-jak-Stat3 signaling prevents wnt-\u03b2-catenin-mediated intestinal tumor growth and regeneration. Sci Signal. 2014;7:ra92. https:\/\/doi.org\/10.1126\/scisignal.2005411.","journal-title":"Sci Signal"},{"key":"7309_CR39","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1128\/MCB.05133-11","volume":"31","author":"R Groppo","year":"2011","unstructured":"Groppo R, Richter JD. CPEB control of NF-kappaB nuclear localization and interleukin-6 production mediates cellular senescence. Mol Cell Biol. 2011;31:2707\u201314. https:\/\/doi.org\/10.1128\/MCB.05133-11.","journal-title":"Mol Cell Biol"},{"key":"7309_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41392-022-01096-7","volume":"7","author":"G Zhao","year":"2022","unstructured":"Zhao G, Yuan H, Li Q, Zhang J, Guo Y, Feng T, et al. DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. Signal Transduct Target Ther. 2022;7:275. https:\/\/doi.org\/10.1038\/s41392-022-01096-7.","journal-title":"Signal Transduct Target Ther"},{"key":"7309_CR41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41419-020-03360-6","volume":"12","author":"C He","year":"2021","unstructured":"He C, Li A, Lai Q, Ding J, Yan Q, Liu S, et al. The DDX39B\/FUT3\/TGF\u03b2R-I axis promotes tumor metastasis and EMT in colorectal cancer. Cell Death Dis. 2021;12:74. https:\/\/doi.org\/10.1038\/s41419-020-03360-6.","journal-title":"Cell Death Dis"},{"key":"7309_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41420-022-00827-7","volume":"8","author":"H Zhang","year":"2022","unstructured":"Zhang H, He C, Guo X, Fang Y, Lai Q, Wang X, et al. DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6\/CCND1. Cell Death Discov. 2022;8:30. https:\/\/doi.org\/10.1038\/s41420-022-00827-7.","journal-title":"Cell Death Discov"},{"key":"7309_CR43","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1080\/15384101.2021.1995129","volume":"20","author":"D Yi","year":"2021","unstructured":"Yi D, Zhang D, He J. Long non-coding RNA LIFR-AS1 suppressed the proliferation, angiogenesis, migration and invasion of papillary thyroid cancer cells via the miR-31-5p\/SIDT2 axis. Cell Cycle. 2021;20:2619\u201337. https:\/\/doi.org\/10.1080\/15384101.2021.1995129.","journal-title":"Cell Cycle"},{"key":"7309_CR44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.isci.2019.09.009","volume":"20","author":"TA Nguyen","year":"2019","unstructured":"Nguyen TA, Bieging-Rolett KT, Putoczki TL, Wicks IP, Attardi LD, Pang KC. SIDT2 RNA transporter promotes lung and gastrointestinal tumor development. iScience. 2019;20:14\u201324. https:\/\/doi.org\/10.1016\/j.isci.2019.09.009.","journal-title":"iScience"},{"key":"7309_CR45","doi-asserted-by":"publisher","first-page":"114865","DOI":"10.1016\/j.bcp.2021.114865","volume":"195","author":"LJ Wang","year":"2022","unstructured":"Wang LJ, Chiou JT, Lee YC, Chang LS. Docetaxel-triggered SIDT2\/NOX4\/JNK\/HuR signaling axis is associated with TNF-\u03b1-mediated apoptosis of cancer cells. Biochem Pharmacol. 2022;195:114865. https:\/\/doi.org\/10.1016\/j.bcp.2021.114865.","journal-title":"Biochem Pharmacol"},{"key":"7309_CR46","doi-asserted-by":"publisher","first-page":"19696","DOI":"10.18632\/aging.203380","volume":"13","author":"D Deng","year":"2021","unstructured":"Deng D, Luo X, Zhang S, Xu Z. Immune cell infiltration-associated signature in colon cancer and its prognostic implications. Aging (albany, NY). 2021;13:19696\u2013709. https:\/\/doi.org\/10.18632\/aging.203380.","journal-title":"Aging (albany, NY)"},{"key":"7309_CR47","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ags3.12369","volume":"4","author":"T Shimizu","year":"2020","unstructured":"Shimizu T, Ishizuka M, Shiraki T, Sakuraoka Y, Mori S, Abe A, et al. The clinical influence of the preoperative lymphocyte-to-monocyte ratio on the postoperative outcome of patients with early-stage gastrointestinal cancer. Ann Gastroenterol Surg. 2020;4:580\u201390. https:\/\/doi.org\/10.1002\/ags3.12369.","journal-title":"Ann Gastroenterol Surg"},{"key":"7309_CR48","doi-asserted-by":"publisher","first-page":"100966","DOI":"10.1016\/j.neo.2024.100966","volume":"48","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liu W, Zhou H, Lai W, Hu C, Dai Y, et al. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma. Neoplasia. 2024;48:100966. https:\/\/doi.org\/10.1016\/j.neo.2024.100966.","journal-title":"Neoplasia"},{"key":"7309_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jare.2024.07.028","volume":"72","author":"W Qiu","year":"2024","unstructured":"Qiu W, Guo R, Yu H, Chen X, Chen Z, Ding D, et al. Single-cell atlas of human gingiva unveils a NETs-related neutrophil subpopulation regulating periodontal immunity. J Adv Res. 2024;72:287\u2013301. https:\/\/doi.org\/10.1016\/j.jare.2024.07.028.","journal-title":"J Adv Res"},{"key":"7309_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40478-024-01837-5","volume":"12","author":"M Motevasseli","year":"2024","unstructured":"Motevasseli M, Darvishi M, Khoshnevisan A, Zeinalizadeh M, Saffar H, Bayat S, et al. Distinct tumor-TAM interactions in IDH-stratified glioma microenvironments unveiled by single-cell and spatial transcriptomics. Acta Neuropathol Commun. 2024;12:133. https:\/\/doi.org\/10.1186\/s40478-024-01837-5.","journal-title":"Acta Neuropathol Commun"},{"key":"7309_CR51","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.bbamcr.2018.06.010","volume":"1865","author":"L Vecchi","year":"2018","unstructured":"Vecchi L, Alves Pereira Z\u00f3ia M, Goss Santos T, de Oliveira Beserra A, Cola\u00e7o Ramos CM, Fran\u00e7a Matias Colombo B, et al. Inhibition of the AnxA1\/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo. Biochim Biophys Acta Mol Cell Res. 2018;1865:1368\u201382. https:\/\/doi.org\/10.1016\/j.bbamcr.2018.06.010.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"7309_CR52","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2478\/acph-2024-0036","volume":"74","author":"M Kor\u017einek","year":"2025","unstructured":"Kor\u017einek M, \u0106elap I, Fabijanec M, \u017dani\u0107 T, Ljubi\u010di\u0107 N, Bar\u0161i\u0107 N, et al. Complete blood count parameters and inflammation-related biomarkers in patients with colorectal carcinoma. Acta Pharm. 2025;74:739\u201349. https:\/\/doi.org\/10.2478\/acph-2024-0036.","journal-title":"Acta Pharm"},{"key":"7309_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/COC.0000000000000183","volume":"40","author":"MM Kozak","year":"2017","unstructured":"Kozak MM, von Eyben R, Pai JS, Anderson EM, Welton ML, Shelton AA, et al. The prognostic significance of pretreatment hematologic parameters in patients undergoing resection for colorectal cancer. Am J Clin Oncol. 2017;40:405\u201312. https:\/\/doi.org\/10.1097\/COC.0000000000000183.","journal-title":"Am J Clin Oncol"},{"key":"7309_CR54","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/cancers13040663","volume":"13","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Adam A, Zhao C, Chen H. Recent advancements in the mechanisms underlying resistance to PD-1\/PD-L1 blockade immunotherapy. Cancers (basel). 2021;13:663. https:\/\/doi.org\/10.3390\/cancers13040663.","journal-title":"Cancers (basel)"},{"key":"7309_CR55","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12931-019-1137-4","volume":"20","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zeng Y, Liu T, Du W, Zhu J, Liu Z, et al. The canonical TGF-\u03b2\/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer. Respir Res. 2019;20:164. https:\/\/doi.org\/10.1186\/s12931-019-1137-4.","journal-title":"Respir Res"},{"key":"7309_CR56","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.3390\/cells11213340","volume":"11","author":"C D\u2019Alterio","year":"2022","unstructured":"D\u2019Alterio C, Giardino A, Scognamiglio G, Butturini G, Portella L, Guardascione G, et al. CXCR4-CXCL12-CXCR7 and PD-1\/PD-L1 in pancreatic cancer: CXCL12 predicts survival of radically resected patients. Cells. 2022;11:3340. https:\/\/doi.org\/10.3390\/cells11213340.","journal-title":"Cells"},{"key":"7309_CR57","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1096\/fj.201802067RR","volume":"33","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Li B, Liang Y, Reeves PM, Qu X, Ran C, et al. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment. Faseb J. 2019;33:6596\u2013608. https:\/\/doi.org\/10.1096\/fj.201802067RR.","journal-title":"Faseb J"},{"key":"7309_CR58","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.62347\/ARYH6451","volume":"14","author":"CY Chang","year":"2024","unstructured":"Chang CY, Chang SC, Wei YF, Tseng YT, Chou CH, Chen YY, et al. Exploring the evolution of T cell function and diversity across different stages of non-small cell lung cancer. Am J Cancer Res. 2024;14:1243\u201357. https:\/\/doi.org\/10.62347\/ARYH6451.","journal-title":"Am J Cancer Res"},{"key":"7309_CR59","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.24.573257","author":"AG Raufi","year":"2023","unstructured":"Raufi AG, Pellicciotta I, Palermo CF, Sastra SA, Chen A, Alouani E, et al. Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4\/PD-1 inhibition in models of pancreatic ductal adenocarcinoma. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.12.24.573257.","journal-title":"bioRxiv"},{"key":"7309_CR60","doi-asserted-by":"publisher","first-page":"111944","DOI":"10.1016\/j.intimp.2024.111944","volume":"132","author":"Y Li","year":"2024","unstructured":"Li Y, Zheng Y, Xu S, et al. The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment. Int Immunopharmacol. 2024;132:111944. https:\/\/doi.org\/10.1016\/j.intimp.2024.111944.","journal-title":"Int Immunopharmacol"},{"key":"7309_CR61","doi-asserted-by":"publisher","first-page":"1194123","DOI":"10.3389\/fimmu.2023.1194123","volume":"14","author":"Y Xu","year":"2023","unstructured":"Xu Y, Ding L, Li H, et al. Serum cytokine analysis in a cohort of advanced non-small cell lung cancer treated with PD-1 inhibitors reveals predictive markers of CXCL12. Front Immunol. 2023;14:1194123. https:\/\/doi.org\/10.3389\/fimmu.2023.1194123. Published 2023 Jun 9.","journal-title":"Front Immunol"},{"issue":"52","key":"7309_CR62","doi-asserted-by":"publisher","first-page":"e2416909121","DOI":"10.1073\/pnas.2416909121","volume":"121","author":"Y Kravtsova-Ivantsiv","year":"2024","unstructured":"Kravtsova-Ivantsiv Y, Goldhirsh G, Ciechanover A. CXCL12 restricts tumor growth by suppressing the ras, ERK1\/2, c-myc, and the immune checkpoint PD-L1 pathways. Proc Natl Acad Sci U S A. 2024;121(52):e2416909121. https:\/\/doi.org\/10.1073\/pnas.2416909121.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07309-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07309-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07309-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:13:01Z","timestamp":1764915181000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07309-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7309"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07309-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Animal Ethics Committee of the First Hospital of Shanxi Medical University, with approval number DWLL-2024\u2013036.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The author(s) declare that no generative AI tools were used in the creation of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI statement"}},{"value":"All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations or those of the publisher, the editors, or the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s note"}},{"value":"We declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1378"}}